Agonists and antagonists for lipopolysaccharide-induced cytokines
- 30 April 1993
- journal article
- review article
- Published by Elsevier in Immunobiology
- Vol. 187 (3-5), 303-316
- https://doi.org/10.1016/s0171-2985(11)80346-3
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Endotoxin-neutralizing capacity of soluble CD14Research in Immunology, 1992
- Modulation of lipopolysaccharide-induced production of tumor necrosis factor, interleukin 1, and interleukin 6 by synthetic precursor Ia of lipid AFEMS Microbiology Letters, 1992
- Macrophage deactivation by interleukin 10.The Journal of Experimental Medicine, 1991
- Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.The Journal of Experimental Medicine, 1991
- Detection of lipopolysaccharide-binding proteins on membranes of murine lymphocyte and macrophage-like cell linesFEMS Microbiology Letters, 1991
- Interleukin-1 receptor antagonist reduces mortality from endotoxin shockNature, 1990
- Lipid IVA inhibits synthesis and release of tumor necrosis factor induced by lipopolysaccharide in human whole blood ex vivo.The Journal of Experimental Medicine, 1990
- BIOCHEMISTRY OF ENDOTOXINSAnnual Review of Biochemistry, 1990
- Synthesis and antitumor activity of lipid A analogs having a phosphonooxyethyl group with .ALPHA.- or .BETA.-configuration at position 1.CHEMICAL & PHARMACEUTICAL BULLETIN, 1990
- Endotoxic properties of chemically synthesized lipid A part structures. Comparison of synthetic lipid A precursor and synthetic analogues with biosynthetic lipid A precursor and free lipid AEuropean Journal of Biochemistry, 1984